Blood DonationDDIDNCT07093307
Docudrama for Blood Donation in Ghana (DDID)
A study testing Docudrama in people with Blood Donation, run by University of Minnesota at 1 site in Ghana.
Trial summary
A cluster pilot RCT to evaluate the effectiveness of the docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Blood Donation
- What is being tested?
- Docudrama
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 202 participants
- Where
- 1 siteGhana
- Study dates
- 11 Aug 2025to 10 Jul 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- At least 18 years-old
- First-time whole blood donor with the SZBC of the NBSG
- Eligible to donate again at the time of eligibility confirmation
- Consent to participate
- Has a valid contact phone number or access to a valid contact phone number
- Understands one of English, Twi, or Ga
- Be willing to watch a docudrama on blood donation
Who cannot join
- History of more than one lifetime whole blood donation (with any blood center)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Using a Docudrama Intervention to Increase Repeat Donation Among First-time Blood Donors in Ghana: a Pilot Cluster Randomized, Pragmatic Type 1 Effectiveness- Implementation Hybrid Trial
A cluster pilot RCT to evaluate the effectiveness of the docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors. Secondary outcomes will be blood donor retention, attitudes, subjective norms, perceived behavioral control and intention as potential mediators of blood donation behavior among first-time blood donors. The cluster pilot RCT will have two arms: 1) docudrama and 2) control. Randomization will stratify by the type of site: mobile versus fixed. Each participant in the docudrama arm will receive the intervention one time immediately after blood donation. Participants in both the docudrama arm and control arm will receive standard blood donor communications and will be followed for six months. Actualized blood donation is possible every four months using NBSG guidelines; however, blood donation sessions may not occur at the blood donation sites until six months. Return blood donation attempts will be evaluated using the Southern Zonal Blood Center (SZBC) records (primary outcome) and participant self-report (secondary outcome) at six months. Secondary measures will be evaluated at baseline and six months from enrollment. The duration of the study will be 11 months, allowing for five months to achieve enrollment goals and six months of follow-up for the last individual enrolled.
- Conditions
- Blood Donation
- Being tested
- Docudrama, Control
- Keywords
- Docudrama
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DocudramaBehavioural
Participants at docudrama sites will watch a 30-minute docudrama (two episodes of 15 minutes each) immediately after blood donation while waiting to recover and to be refreshed.
ControlBehavioural
Participants randomized at control sites will receive the standard NBSG communications for blood donors: 1) a "thank you" phone call and 2) and a reminder phone call two-weeks prior to when they are due for their next blood donation.
| Study group | Role | What they receive |
|---|---|---|
| Docudrama | Experimental | Not described Receives: Behavioral: Docudrama |
| Control | Active comparator | Not described Receives: Behavioral: Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of participants with a verified repeat blood donation attempt
Self-report of a blood donation attempt at the 6 month follow-up phone call using a questionnaire that is administered by study research staff over the phone. Self-reported attempts are then verified using the National Blood Services Ghana (NBSG) national blood donation database.
Measured: Within 6 months after randomization
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jul 2025
- Study start11 Aug 2025
- Primary completion10 Jul 2026
- Study completion10 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood DonationStudies of the same condition, open and under way.
- More trials run by University of MinnesotaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Cluster randomized
- Masking
- None (open label)
- Enrolment
- 202 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Minnesota
- Sponsor type
- University, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI), Syracuse University, National Blood Service Ghana, University of Ghana
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07093307
- Sponsor's protocol ID
- B11
- Other IDs
- 4UH3HL151599-03
- Acronym
- DDID
- Status last verified
- Sep 2026
- First submitted
- 8 Jul 2025
- Last updated
- 9 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 9 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Using a Docudrama Intervention to Increase Repeat Donation Among First-time Blood Donors in Ghana: a Pilot Cluster Randomized, Pragmatic Type 1 Effectiveness- Implementation Hybrid Trial
- ClinicalTrials.gov ID
- NCT07093307
- Acronym / sponsor ID
- DDID / B11
- Conditions
- Blood Donation
- Keywords
- Docudrama
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 202 participants (actual)
- Lead sponsor
- University of MinnesotaUniversity, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI), Syracuse University, National Blood Service Ghana, University of Ghana
- Study start
- 11 Aug 2025 (actual)
- Primary completion
- 10 Jul 2026 (actual)
- Study completion
- 10 Jul 2026 (actual)
- First posted
- 30 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A cluster pilot RCT to evaluate the effectiveness of the docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors. Secondary outcomes will be blood donor retention, attitudes, subjective norms, perceived behavioral control and intention as potential mediators of blood donation behavior among first-time blood donors. The cluster pilot RCT will have two arms: 1) docudrama and 2) control. Randomization will stratify by the type of site: mobile versus fixed. Each participant in the docudrama arm will receive the intervention one time immediately after blood donation. Participants in both the docudrama arm and control arm will receive standard blood donor communications and will be followed for six months. Actualized blood donation is possible every four months using NBSG guidelines; however, blood donation sessions may not occur at the blood donation sites until six months. Return blood donation attempts will be evaluated using the Southern Zonal Blood Center (SZBC) records (primary outcome) and participant self-report (secondary outcome) at six months. Secondary measures will be evaluated at baseline and six months from enrollment. The duration of the study will be 11 months, allowing for five months to achieve enrollment goals and six months of follow-up for the last individual enrolled.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Cluster randomized
| Arm | Type | Receives |
|---|---|---|
| Docudrama | Experimental | Behavioral: Docudrama |
| Control | Active comparator | Behavioral: Control |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- At least 18 years-old
- First-time whole blood donor with the SZBC of the NBSG
- Eligible to donate again at the time of eligibility confirmation
- Consent to participate
- Has a valid contact phone number or access to a valid contact phone number
Key exclusion criteria (1 listed)
- History of more than one lifetime whole blood donation (with any blood center)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DocudramaParticipants at docudrama sites will watch a 30-minute docudrama (two episodes of 15 minutes each) immediately after blood donation while waiting to recover and to be refreshed. | Behavioural | Docudrama |
| ControlParticipants randomized at control sites will receive the standard NBSG communications for blood donors: 1) a "thank you" phone call and 2) and a reminder phone call two-weeks prior to when they are due for their next blood donation. | Behavioural | Control |
Primary outcome
Proportion of participants with a verified repeat blood donation attempt
Time frame: Within 6 months after randomization
Self-report of a blood donation attempt at the 6 month follow-up phone call using a questionnaire that is administered by study research staff over the phone. Self-reported attempts are then verified using the National Blood Services Ghana (NBSG) national blood donation database.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Sep 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Blood Donation
Active, not recruitingPhase 2
Treatment of Hemochromatosis
Hemochromatosis
RecruitingObservational study
Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy
Healthy Volunteer
Not yet recruiting
Cookies for Platelets
Blood Donation
RecruitingPhase 2/3
Autologous Cold-stored Apheresis Platelets
Bleeding, Platelets
RecruitingPhase 4
Improving White Blood Cell Collection From Healthy Donors
Allogeneic Granulocyte Donation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Docudrama in people with Blood Donation, run by University of Minnesota at 1 site in Ghana.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Ghana. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of participants with a verified repeat blood donation attempt (time frame: Within 6 months after randomization). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2026.